BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37934575)

  • 1. An in vitro model for vitamin A transport across the human blood-brain barrier.
    Est CB; Murphy RM
    Elife; 2023 Nov; 12():. PubMed ID: 37934575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro model for vitamin A transport across the human blood-brain barrier.
    Est CB; Murphy RM
    bioRxiv; 2023 Apr; ():. PubMed ID: 37090623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells.
    Hollmann EK; Bailey AK; Potharazu AV; Neely MD; Bowman AB; Lippmann ES
    Fluids Barriers CNS; 2017 Apr; 14(1):9. PubMed ID: 28407791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryopreservation of Brain Endothelial Cells Derived from Human Induced Pluripotent Stem Cells Is Enhanced by Rho-Associated Coiled Coil-Containing Kinase Inhibition.
    Wilson HK; Faubion MG; Hjortness MK; Palecek SP; Shusta EV
    Tissue Eng Part C Methods; 2016 Dec; 22(12):1085-1094. PubMed ID: 27846787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells.
    Canfield SG; Stebbins MJ; Morales BS; Asai SW; Vatine GD; Svendsen CN; Palecek SP; Shusta EV
    J Neurochem; 2017 Mar; 140(6):874-888. PubMed ID: 27935037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isogenic blood-brain barrier models based on patient-derived stem cells display inter-individual differences in cell maturation and functionality.
    Patel R; Page S; Al-Ahmad AJ
    J Neurochem; 2017 Jul; 142(1):74-88. PubMed ID: 28397247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
    Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
    Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix stiffness regulates the tight junction phenotypes and local barrier properties in tricellular regions in an iPSC-derived BBB model.
    Yan L; Dwiggins CW; Moriarty RA; Jung JW; Gupta U; Brandon KD; Stroka KM
    Acta Biomater; 2023 Sep; 167():109-120. PubMed ID: 37302732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Group B
    Kim BJ; Bee OB; McDonagh MA; Stebbins MJ; Palecek SP; Doran KS; Shusta EV
    mSphere; 2017; 2(6):. PubMed ID: 29104935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Drug Permeability Using
    Ohshima M; Kamei S; Fushimi H; Mima S; Yamada T; Yamamoto T
    Biores Open Access; 2019; 8(1):200-209. PubMed ID: 31737437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An isogenic neurovascular unit model comprised of human induced pluripotent stem cell-derived brain microvascular endothelial cells, pericytes, astrocytes, and neurons.
    Canfield SG; Stebbins MJ; Faubion MG; Gastfriend BD; Palecek SP; Shusta EV
    Fluids Barriers CNS; 2019 Aug; 16(1):25. PubMed ID: 31387594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Models of the blood-brain barrier using iPSC-derived cells.
    Delsing L; Herland A; Falk A; Hicks R; Synnergren J; Zetterberg H
    Mol Cell Neurosci; 2020 Sep; 107():103533. PubMed ID: 32717317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of RARα, RARγ, or RXRα Increases Barrier Tightness in Human Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells.
    Stebbins MJ; Lippmann ES; Faubion MG; Daneman R; Palecek SP; Shusta EV
    Biotechnol J; 2018 Feb; 13(2):. PubMed ID: 28960887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear receptor ligand screening in an iPSC-derived in vitro blood-brain barrier model identifies new contributors to leptin transport.
    Shi Y; Kim H; Hamann CA; Rhea EM; Brunger JM; Lippmann ES
    Fluids Barriers CNS; 2022 Sep; 19(1):77. PubMed ID: 36131285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defined Differentiation of Human Pluripotent Stem Cells to Brain Microvascular Endothelial-Like Cells for Modeling the Blood-Brain Barrier.
    Foreman KL; Shusta EV; Palecek SP
    Methods Mol Biol; 2023; 2683():113-133. PubMed ID: 37300771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro.
    Raut S; Patel R; Al-Ahmad AJ
    Fluids Barriers CNS; 2021 Jan; 18(1):3. PubMed ID: 33413468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D.
    Jamieson JJ; Linville RM; Ding YY; Gerecht S; Searson PC
    Fluids Barriers CNS; 2019 Jun; 16(1):15. PubMed ID: 31167667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Glycogen Synthase Kinase 3ß Enhances Functions of Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells in the Blood-Brain Barrier.
    Yamaguchi T; Nishijima M; Kawabata K
    Biol Pharm Bull; 2022; 45(10):1525-1530. PubMed ID: 36184511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of transforming growth factor beta signaling pathway promotes differentiation of human induced pluripotent stem cell-derived brain microvascular endothelial-like cells.
    Yamashita M; Aoki H; Hashita T; Iwao T; Matsunaga T
    Fluids Barriers CNS; 2020 May; 17(1):36. PubMed ID: 32456699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress and new challenges in modeling of human pluripotent stem cell-derived blood-brain barrier.
    Yan L; Moriarty RA; Stroka KM
    Theranostics; 2021; 11(20):10148-10170. PubMed ID: 34815809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.